Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilastine vs Cetirizine in Perennial Allergic Rhinitis
NCT01127620Phase 3Completed
- Sponsor
- Faes Farma
- Start
- May 2004
- Primary completion
- Mar 2006
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of bilastine in perennial allergic rhinitis (PAR), sponsored by Faes Farma. Started May 2004; status: completed.
02
Drugs
bilastine
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT01127620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01127620.